Rina-S is the last candidate standing from Genmab’s $1.8 billion ProfoundBio acquisition two years ago, with the Danish ...

Back in the day where the microprocessor was our standard building block, we tended to concentrate on computation and processing of data and not so much on I/O. Simply put there were a lot of things ...

Antibody-drug conjugates (ADCs) are transforming oncology with their ability to deliver potent cytotoxic agents directly to ...